OptoTree is a privately held and funded LLC. We are currently in process of raising next round of capital to complete productization and regulatory approvals for the “Diabetic Retinopathy Biomarker as a Service” solution. Investment parties interested in the field of retina disease diagnosis and Diabetic Retinopathy should email Raul Brauner CEO at raulb@bio-tree.com.